4//SEC Filing
Eleven Biotherapeutics, Inc. 4
Accession 0001485003-16-000168
$CARMCIK 0001485003operating
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:45 PM ET
Size
5.7 KB
Accession
0001485003-16-000168
Insider Transaction Report
Form 4
Celniker Abbie
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2016-09-20+29,988→ 90,000 totalExercise: $0.28From: 2016-09-20Exp: 2026-02-24→ Common Stock (29,988 underlying)
Footnotes (1)
- [F1]On February 25, 2016, the reporting person was granted an option to purchase 90,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 29,988 shares. The option had previously vested with respect to 60,012 shares.
Documents
Issuer
Eleven Biotherapeutics, Inc.
CIK 0001485003
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001485003
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 4:45 PM ET
- Size
- 5.7 KB